Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate to Prevent Post-ERCP Pancreatitis: a Multicentre, Non-inferiority, Double-blind, Randomised Trial

NCT04425993 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT04425993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04425993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate to Prevent Post-ERCP Pancreatitis: a Multicentre, Non-inferiority, Double-blind, Randomised Trial
Lead sponsor
Air Force Military Medical University, China
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2020
Completion date
December 30, 2022
Enrollment
2,700 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp acute pancreatitis